Assays for Vitamins and Metabolic Function
JH · Effective Oct 1, 2015
34 active Medicare policies list L40.1, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Nov 1, 2022
2 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of L40.1 |
|---|---|---|
| Spevigo (Spesolimab-Sbzo) | Jun 1, 2026 | Covered |
| Spevigo (Spesolimab-Sbzo) – IV and Subcutaneous Formulations (for UHCWest Only) | Jun 1, 2026 | Covered |
JK · Effective Nov 1, 2022
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Mar 5, 2023
JM · Effective Mar 5, 2023
J6 · Effective Apr 1, 2018
JK · Effective Apr 1, 2018
JE · Effective Feb 3, 2017
JF · Effective Feb 3, 2017
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JL · Effective Oct 1, 2025
J5 · Effective Nov 27, 2025
National · Effective Jan 1, 2026
J6 · Effective Oct 1, 2024
J6 · Effective Oct 1, 2025
JL · Effective Jan 1, 2026
J9 · Effective Jan 1, 2026
National · Effective Jan 1, 2026
J5 · Effective Oct 1, 2024
National · Effective Aug 14, 2025
J6 · Effective Oct 1, 2024
J9 · Effective Oct 1, 2023